Cargando…
Development History and Concept of an Oral Anticancer Agent S-1 (TS-1(®)): Its Clinical Usefulness and Future Vistas
Dushinsky et al. left a great gift to human beings with the discovery of 5-fluorouracil (5-FU). Approximately 50 years have elapsed from that discovery to the development of S-1 (TS-1(®)). The concept of developing an anticancer agent that simultaneously possesses both efficacy-enhancing and adverse...
Autor principal: | Shirasaka, Tetsuhiko |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639406/ https://www.ncbi.nlm.nih.gov/pubmed/19052037 http://dx.doi.org/10.1093/jjco/hyn127 |
Ejemplares similares
-
Vistas for the future
por: Grewal, Anju
Publicado: (2015) -
VISTAS of the Future
por: Basu, Ashoke Kumar
Publicado: (2019) -
Abnormalities in the meibomian glands in patients with oral administration of anticancer combination drug-capsule TS-1(®): a case report
por: Mizoguchi, Shin, et al.
Publicado: (2015) -
VISTA expression and patient selection for immune-based anticancer therapy
por: Martin, Alexander S., et al.
Publicado: (2023) -
Changing visions in ESP development and teaching: Past, present, and future vistas
por: Dou, An Qi, et al.
Publicado: (2023)